{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:22:15Z","timestamp":1774617735503,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12969-017-0188-7","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T12:10:13Z","timestamp":1501157413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Co-existence of Blau syndrome and NAID? Diagnostic challenges associated with presence of multiple pathogenic variants in NOD2 gene: a case report"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1197-6917","authenticated-orcid":false,"given":"Magdalena","family":"Dziedzic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Marja\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"B\u0105bol-Pokora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Urba\u0144czyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Grze\u015bk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"M\u0142ynarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylwia","family":"Ko\u0142tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"188_CR1","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/ar3462","volume":"13","author":"Q Yao","year":"2011","unstructured":"Yao Q, Zhou L, Cusumano P, Bose N, Piliang M, Jayakar B, et al. A new category of autoinflammdisease associated with NOD2 gene mutations. Arthritis Res Ther. 2011;13:R148.","journal-title":"Arthritis Res Ther"},{"key":"188_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri3565","volume":"14","author":"DJ Philpott","year":"2014","unstructured":"Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE. NOD proteins: regulators of inflammation in health and disease. Nat Rev Immunol. 2014;14:9\u201323.","journal-title":"Nat Rev Immunol"},{"key":"188_CR3","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1002\/art.22966","volume":"56","author":"JI Ar\u00f3stegui","year":"2007","unstructured":"Ar\u00f3stegui JI, Arnal C, Merino R, Modesto C, Antonia Carballo M, Moreno P, et al. NOD2 gene-associated pediatric granulomatous arthritis. Arthritis Rheum. 2007;56:3805\u201313.","journal-title":"Arthritis Rheum"},{"key":"188_CR4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clim.2009.05.005","volume":"134","author":"A Borzutzky","year":"2010","unstructured":"Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F. NOD2-associated diseases: bridging innate immunity and autoinflammation. Clin Immunol. 2010;134:251\u201361.","journal-title":"Clin Immunol"},{"key":"188_CR5","first-page":"1","volume":"20","author":"F Caso","year":"2015","unstructured":"Caso F, Galozzi P, Costa L, Sfriso P, Cantarini L, Punzi L. Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn\u2019s disease. RMD Open. 2015;20:1.","journal-title":"RMD Open"},{"key":"188_CR6","unstructured":"The registry of Hereditary Auto-inflammatory Disorders Mutations. A HGVS affiliated database. http:\/\/fmf.igh.cnrs.fr\/ISSAID\/infevers\/search.php?n=6 . Accessed 7 Jan 2017."},{"key":"188_CR7","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/rheumatology\/kev207","volume":"54","author":"Q Yao","year":"2015","unstructured":"Yao Q, Shen M, McDonald C, Lacbawan F, Moran R, Shen B. NOD2-associated autoinflammatory disease: a large cohort study. Rheumatology. 2015;54:1904\u201312.","journal-title":"Rheumatology"},{"key":"188_CR8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaip.2016.02.016","volume":"4","author":"Q Yao","year":"2016","unstructured":"Yao Q, Shen M, Fernandez J. NOD2-associated autoinflammatory disease and immune deficiency. J Allergy Clin Immunol Pract. 2016;4:780\u20132.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"188_CR9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2012.09.025","volume":"68","author":"Q Yao","year":"2013","unstructured":"Yao Q, Su LC, Tomecki KJ, Zhou L, Jayakar B, Shen B. Dermatitis as a characteristic phenotype of a new autoinflammatory disease associated with NOD2 mutations. J Am Acad Dermatol. 2013;68:624\u201331.","journal-title":"J Am Acad Dermatol"},{"key":"188_CR10","doi-asserted-by":"crossref","first-page":"A208","DOI":"10.1186\/1546-0096-11-S1-A208","volume":"11","author":"M Pardeo","year":"2013","unstructured":"Pardeo M, Cortis E, Bracaglia C, Nicolai R, De Benedetti F, Insalaco A. P03-012 - A P268S NOD2 mutation in one Blau patient. Pediatr Rheumatol Online J. 2013;11:A208.","journal-title":"Pediatr Rheumatol Online J"},{"key":"188_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood-2004-10-3835","volume":"105","author":"N Kanazawa","year":"2005","unstructured":"Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-B activation: common genetic etiology with Blau syndrome. Blood. 2005;105:3.","journal-title":"Blood"},{"key":"188_CR12","doi-asserted-by":"publisher","unstructured":"Iwasaki T, Kaneko N, Ito Y, Takeda H, Sawasaki T, Heike T, et al. Nod2-Nodosome in a Cell-Free System: Implications in Pathogenesis and Drug Discovery for Blau Syndrome and Early-Onset Sarcoidosis. Sci World J. 2016; doi: 10.1155\/2016\/2597376 .","DOI":"10.1155\/2016\/2597376"},{"key":"188_CR13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/cei.12178","volume":"174","author":"R Ameratunga","year":"2013","unstructured":"Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol. 2013;174:203\u201311.","journal-title":"Clin Exp Immunol"},{"key":"188_CR14","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.autrev.2014.08.010","volume":"13","author":"F Caso","year":"2014","unstructured":"Caso F, Costa L, Rigante D, Vitale A, Cimaz R, Lucherini OM, et al. Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. Autoimmun Rev. 2014;13:1220\u20139.","journal-title":"Autoimmun Rev"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-017-0188-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T14:59:00Z","timestamp":1659279540000},"score":1,"resource":{"primary":{"URL":"http:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-017-0188-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["188"],"URL":"https:\/\/doi.org\/10.1186\/s12969-017-0188-7","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]},"article-number":"57"}}